BNXT — BioNxt Solutions Balance Sheet
0.000.00%
- CA$66.65m
- CA$74.51m
- CA$0.03m
Annual balance sheet for BioNxt Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 2.58 | 1.35 | 0.136 | 0.364 | 0.032 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.306 | 0.546 | 0.459 | 0.283 | 0.061 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 3.03 | 2.7 | 0.691 | 0.719 | 0.164 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.24 | 1.13 | 0.921 | 0.549 | 0.406 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 8.28 | 9.73 | 1.61 | 1.27 | 0.569 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.47 | 5.45 | 2.02 | 6.55 | 6.88 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 4.28 | 8.06 | 5.74 | 6.55 | 8.43 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 4.01 | 1.67 | -4.13 | -5.28 | -7.86 |
| Total Liabilities & Shareholders' Equity | 8.28 | 9.73 | 1.61 | 1.27 | 0.569 |
| Total Common Shares Outstanding |